As reported: during the study 30-day conducted on (b)(6) 2021 it was reported that 3 days post-procedure the patient suffered new onset of a-fib with rates to 120 bpm and frequent pvcs.This new onset of a-fib is probably attributed to the volume overload and myocardial manipulation performed during the index procedure performed on (b)(6) 2021 of a cto pci of the proximal rca in which a turnpike (study device), trapliner (study device), spectre guidewire (study device) and raider guidewire (study device) were used.Patient was treated with sync-cardioversion and medical management with amiodarone load.This event was resolved with no sequelae.Mdrs associated to: mdr 2134812-2021-00017 raider gw.Mdr 2134812-2021-00018 spectre gw.Mdr 2134812-2021-00019 trapliner.
|
There was no product returned for this complaint.No returned product evaluation could be completed.The lot # was reviewed.There are no non-conformities related to this lot therefore supporting the device met material, assembly and performance specifications.Account stated that the new onset of a-fib is probably attributed to the volume overload and myocardial manipulation performed during the index procedure.The symptom is a heart rhythm related issue and not directly related to the use of turnpike.Based on limited procedural information, it is unknown if turnpike contributed to adverse event.Patient was treated with sync-cardioversion and medical management with amiodarone load.This event was resolved with no sequelae.Based on the information, the most likely root cause is undeterminable.
|